NCT04723095Recruiting
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 750 (estimated)
- First submitted
- 13 Oct 2020
- Start date
- 16 May 2013
- Primary completion date
- 1 Jan 2044
- Lead sponsor
- M.D. Anderson Cancer Center
- NCT number
- NCT04723095
What you commit to
- Study type: Observational
- Planned participants: 750
- From 16 May 2013 to the primary completion date, 1 Jan 2044
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients with other histologic subtypes of NEC of the cervix including typical and atypical carcinoid tumors
Who the study is looking for
- Patients with a personal history of cervical cancer with any portion of neuroendocrine component (including mixed tumors) of the following histologic subtypes:
- Small cell neuroendocrine carcinoma
- Large cell neuroendocrine carcinoma
- Undifferentiated high-grade neuroendocrine carcinoma
- Patients may be in any stage of treatment, surveillance or recurrence at the time of initial participation in the study
- Patients with all stages of disease are considered eligible
- Patients who do not speak English can be eligible if accompanied by an institutional interpreter
- Patients who are receiving or have received treatment at any facility, including but not limited to M. D. Anderson Cancer Center are eligible
- Patient may be residents of any country and be of any ethnic background
- Patients who request to participate in the study, regardless of the method by which they learned of it, are eligible to participate, including, but not limited to patients who seek participation via the website
- Next of kin or legal authorized representatives of patients who are deceased but had a history of neuroendocrine carcinoma (NEC) of the cervix are eligible to participate
- Next of kin or legal authorized representatives of patients must read and speak English
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.